High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates

Bioorg Med Chem. 2006 Aug 1;14(15):5220-9. doi: 10.1016/j.bmc.2006.04.001. Epub 2006 May 2.

Abstract

Various high-mannose-type glycan modifications of dihydrofolate reductase (DHFR) were achieved by ligand-based approach using glycan-methotrexate (MTX) conjugates as tight binding glycan bearing ligands for DHFR. The resulting glycan-MTX conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide- and glycoprotein-probes to perform quantitative analysis of glycan recognizing protein such as lectins, glycosyltransferases or glycosidases. Moreover, artificial glycoproteins having two different high-mannose-type glycans were developed for the first time by a combination of two different types of glycan modification strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Ligands
  • Mannose / chemistry*
  • Methotrexate / analogs & derivatives
  • Methotrexate / chemistry
  • Methotrexate / pharmacology*
  • Molecular Structure
  • Polysaccharides / chemical synthesis
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • Protein Conformation
  • Protein Structure, Tertiary
  • Structure-Activity Relationship
  • Tetrahydrofolate Dehydrogenase / chemistry
  • Tetrahydrofolate Dehydrogenase / drug effects*

Substances

  • Ligands
  • Polysaccharides
  • Tetrahydrofolate Dehydrogenase
  • Mannose
  • Methotrexate